|
1
|
Riberi A, Gariboldi V, Grisoli D, et al:
Cardiac tumors. Rev Pneumol Clin. 66:95–103. 2010.
|
|
2
|
Carney JA, Gordon H, Carpenter PC, et al:
The complex of myxomas, spotty pigmentation, and endocrine
overactivity. Medicine (Baltimore). 64:270–283. 1985.
|
|
3
|
Rhodes AR, Silverman RA, Harrist TJ, et
al: Mucocutaneous lentigines, cardiomucocutaneous myxomas, and
multiple blue nevi: the ‘LAMB’ syndrome. J Am Acad Dermatol.
10:72–82. 1984.
|
|
4
|
Burke AP, Tazeelar H, Gomez-Roman JJ, et
al: Benign tumours of pluripotent mesenchyme. World Health
Organization Tumours of the Lung, Pleura, Thymus and Heart. Travis
WD, Brambilla E, Muller-Hermelink HK and Harris CC: IARC Press;
Lyon: pp. 260–265. 2004
|
|
5
|
Ribatti D and Crivellato E: The
controversial role of mast cells in tumor growth. Int Rev Cell Mol
Biol. 275:89–131. 2009.
|
|
6
|
Ribatti D, Crivellato E, Roccaro AM, et
al: Mast cell contribution to angiogenesis related to tumour
progression. Clin Exp Allergy. 34:1660–1664. 2004.
|
|
7
|
Benitez-Bribiesca L, Wong A, Utrera D, et
al: The role of mast cell tryptase in neoangiogenesis of
premalignant and malignant lesions of the uterine cervix. J
Histochem Cytochem. 49:1061–1062. 2001.
|
|
8
|
McNeil HP, Adachi R and Stevens RL: Mast
cell-restricted tryptases: structure and function in inflammation
and pathogen defense. J Biol Chem. 282:20785–20789. 2007.
|
|
9
|
Ammendola M, Zuccala V, Patruno R, et al:
Tryptase-positive mast cells and angiogenesis in keloids: a new
possible post-surgical target for prevention. Updates Surg.
65:53–57. 2013.
|
|
10
|
Weidner N, Semple JP, Welch WR, et al:
Tumor angiogenesis and metastasis - correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991.
|
|
11
|
Acebo E, Val-Bernal JF and Gomez-Roman JJ:
Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac
myxoma. Histol Histopathol. 16:1031–1036. 2001.
|
|
12
|
Arock M, Schneider E, Boissan M, et al:
Differentiation of human basophils: an overview of recent advances
and pending questions. J Leukoc Biol. 71:557–564. 2002.
|
|
13
|
Sperr WR, Bankl HC, Mundigler G, et al:
The human cardiac mast cell: localization, isolation, phenotype,
and functional characterization. Blood. 84:3876–3884. 1994.
|
|
14
|
Donato G, Conforti F, Zuccala V, et al:
Expression of tenascin-c and CD44 receptors in cardiac myxomas.
Cardiovasc Pathol. 18:173–177. 2009.
|
|
15
|
Orlandi A, Ciucci A, Ferlosio A, et al:
Cardiac myxoma cells exhibit embryonic endocardial stem cell
features. J Pathol. 209:231–239. 2006.
|
|
16
|
Zhou Y, Pan P, Yao L, et al:
CD117-positive cells of the heart: progenitor cells or mast cells?
J Histochem Cytochem. 58:309–316. 2010.
|
|
17
|
Harris IS and Black BL: Development of the
endocardium. Pediatr Cardiol. 31:391–399. 2010.
|
|
18
|
Milgrom-Hoffman M, Harrelson Z, Ferrara N,
et al: The heart endocardium is derived from vascular endothelial
progenitors. Development. 138:4777–4787. 2011.
|
|
19
|
Andrews RG, Singer JW and Bernstein ID:
Monoclonal antibody 12-8 recognizes a 115-kd molecule present on
both unipotent and multipotent hematopoietic colony-forming cells
and their precursors. Blood. 67:842–845. 1986.
|
|
20
|
Krause DS, Fackler MJ, Civin CI, et al:
CD34: structure, biology, and clinical utility. Blood. 87:1–13.
1996.
|
|
21
|
Nielsen JS and McNagny KM: CD34 is a key
regulator of hematopoietic stem cell trafficking to bone marrow and
mast cell progenitor trafficking in the periphery.
Microcirculation. 16:487–496. 2009.
|
|
22
|
van Beijnum JR, van der Linden E and
Griffioen AW: Angiogenic profiling and comparison of immortalized
endothelial cells for functional genomics. Exp Cell Res.
314:264–272. 2008.
|
|
23
|
Siemerink MJ, Klaassen I, Vogels IM, et
al: CD34 marks angiogenic tip cells in human vascular endothelial
cell cultures. Angiogenesis. 15:151–163. 2012.
|
|
24
|
Theoharides TC and Conti P: Mast cells:
the Jekyll and Hyde of tumor growth. Trends Immunol. 25:235–241.
2004.
|
|
25
|
Dyduch G, Kaczmarczyk K and Okon K: Mast
cells and cancer: enemies or allies? Pol J Pathol. 63:1–7.
2012.
|
|
26
|
Ribatti D, Finato N, Crivellato E, et al:
Neovascularization and mast cells with tryptase activity increase
simultaneously with pathologic progression in human endometrial
cancer. Am J Obstet Gynecol. 193:1961–1965. 2005.
|
|
27
|
Takanami I, Takeuchi K and Naruke M: Mast
cell density is associated with angiogenesis and poor prognosis in
pulmonary adenocarcinoma. Cancer. 88:2686–2692. 2000.
|
|
28
|
Ammendola M, Sacco R, Donato G, et al:
Mast cell positivity to tryptase correlates with metastatic lymph
nodes in gastrointestinal cancer patients treated surgically.
Oncology. 85:111–116. 2013.
|
|
29
|
Ribatti D, Guidolin D, Marzullo A, et al:
Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol.
91:350–356. 2010.
|
|
30
|
Groot Kormelink T, Abudukelimu A and
Redegeld FA: Mast cells as target in cancer therapy. Curr Pharm
Des. 5:1868–1878. 2009.
|
